logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Epithelial Ovarian Carcinoma

    FiltersReset Filters
    4 results

    • carboplatin

      (CARBOPLATIN)
      Fresenius Kabi USA, LLC
      Usage: Carboplatin Injection is indicated for the palliative treatment of patients with recurrent ovarian carcinoma after prior chemotherapy, including those previously treated with cisplatin, especially in cases where patients have progressive disease during cisplatin therapy, which may result in decreased response rates.

    • carboplatin

      (Carboplatin)
      Gland Pharma Limited
      Usage: Carboplatin injection is indicated for the initial treatment of advanced ovarian carcinoma in combination with other chemotherapy agents, and for palliative treatment of recurrent ovarian carcinoma after prior chemotherapy, including in patients previously treated with cisplatin.

    • carboplatin

      (CARBOPLATIN)
      Eugia US LLC
      Usage: Carboplatin injection is indicated for the initial and palliative treatment of advanced ovarian carcinoma, used in combination with other approved chemotherapy agents. It is effective for patients who have recurrent ovarian carcinoma after prior treatment, including those previously treated with cisplatin.

    • doxorubicin hydrochloride

      (DOXORUBICIN HYDROCHLORIDE)
      Fresenius Kabi USA, LLC
      Usage: Doxorubicin Hydrochloride Injection is indicated for treating various cancers, including leukemias, Wilms' tumor, neuroblastoma, sarcomas, and several carcinomas. It is also used as adjuvant therapy for women with axillary lymph node involvement post-primary breast cancer resection.